Quorum Health (NYSE:QHC) was upgraded by Zacks Investment Research from a “sell” rating to a “hold” rating in a note issued to investors on Friday.

According to Zacks, “Quorum Health Corporation provides hospital and outpatient healthcare services in the United States. The Company operates in two segments: Hospital operations, which includes its general acute care hospitals and related healthcare entities that provide inpatient and outpatient healthcare services, and hospital management advisory and consulting services, which includes Quorum Health Resources, LLC (QHR). It operates QHR, which is a hospital management advisory and consulting services that provides services to non-affiliated general acute care hospitals. Its hospitals and its affiliated businesses offer services, such as general acute care, emergency room, general and specialty surgery, critical care, internal medicine, obstetric, diagnostic, psychiatric, and rehabilitation services. “

QHC stock opened at $1.77 on Friday. The stock has a market capitalization of $55.81 million, a PE ratio of -1.08 and a beta of 2.05. Quorum Health has a 12 month low of $1.73 and a 12 month high of $10.00.

Quorum Health (NYSE:QHC) last released its quarterly earnings data on Tuesday, March 12th. The company reported ($0.32) earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.27) by ($0.05). Quorum Health had a negative net margin of 10.66% and a negative return on equity of 248.56%. The firm had revenue of $458.63 million during the quarter. On average, equities research analysts forecast that Quorum Health will post -1.29 EPS for the current fiscal year.

Several institutional investors have recently added to or reduced their stakes in QHC. Northern Trust Corp increased its stake in shares of Quorum Health by 334.6% in the second quarter. Northern Trust Corp now owns 327,564 shares of the company’s stock valued at $1,638,000 after buying an additional 252,187 shares during the period. JPMorgan Chase & Co. increased its stake in shares of Quorum Health by 1,438.5% in the third quarter. JPMorgan Chase & Co. now owns 844,488 shares of the company’s stock valued at $4,949,000 after buying an additional 789,598 shares during the period. Credit Suisse AG increased its stake in shares of Quorum Health by 159.1% in the third quarter. Credit Suisse AG now owns 883,707 shares of the company’s stock valued at $5,179,000 after buying an additional 542,580 shares during the period. Connor Clark & Lunn Investment Management Ltd. increased its stake in shares of Quorum Health by 29.2% in the third quarter. Connor Clark & Lunn Investment Management Ltd. now owns 129,530 shares of the company’s stock valued at $759,000 after buying an additional 29,300 shares during the period. Finally, GSA Capital Partners LLP increased its stake in shares of Quorum Health by 72.9% in the third quarter. GSA Capital Partners LLP now owns 24,032 shares of the company’s stock valued at $141,000 after buying an additional 10,132 shares during the period. 92.76% of the stock is owned by institutional investors.

Quorum Health Company Profile

Quorum Health Corporation provides hospital and outpatient healthcare services in the United States. Its hospital and outpatient healthcare services include general and acute care, emergency room, general and specialty surgery, critical care, internal medicine, obstetric, diagnostic, psychiatric, and rehabilitation services.

Further Reading: What economic reports are most valuable to investors?

Get a free copy of the Zacks research report on Quorum Health (QHC)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Quorum Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Quorum Health and related companies with MarketBeat.com's FREE daily email newsletter.